YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
VANCOUVER, BC, Oct. 3, 2026 /PRNewswire/ -- Stock Preachers News Commentary - Big technology names pulled the Nasdaq Composite to a weekly gain while the Dow Jones Industrial Average and Russell 2000 closed the week in the red, underscorin…
Axogen Inc.(NASDAQ:AXGN) on Thursday agreed to acquire a privately held medical device manufacturer, BioCircuit Technologies Inc., for $200 million in cash. The strategic acquisition integrates NerveTape, the first FDA-approved sutureless…
Medical-device stocks Cooper Companies Inc (NASDAQ:COO) and Axogen Inc (NASDAQ:AXGN) are both sharply lower following separate company developments, and options traders are chiming in. Cooper Companies stock is down 14.9% at $54.04 at last…
NZS Capital, LLC, an investment management company, released its "NZS Growth Equity Strategy" second-quarter 2026 investor letter. A copy of the letter can be downloaded here. Equity markets delivered a strong performance in the second qua…
This article first appeared on GuruFocus. NZS Growth Equity Strategy added Nvidia (NASDAQ:NVDA) back to its portfolio during the second quarter while increasing stakes in several high-conviction technology and healthcare names. The fund re…
(RTTNews) - Neuronetics, Inc. (STIM), which provides treatment options for neurohealth disorders, announced that Nir Naor has been appointed Chief Financial Officer or CFO effective July 23, 2026. Separately, the company also promoted Cory…
Nir Naor appointed Chief Financial Officer effective July 23, 2026, bringing more than 20 years of finance and life sciences experienceCory Anderson promoted to Executive Vice President and General Manager, Greenbrook effective July 1, 202…
Dow Jones AI giant Nvidia stock tumbled to a key support level during Tuesday's stock market sell-off. A decisive bounce would be bullish. Continue Reading
Eli Lilly leads three health care stocks to watch as the market appears to be rotating into medicals. Google stock is finding key support too. Continue Reading
Issued on behalf of Conexeu Sciences Inc. A biotech debut out of Reno is betting that the next wave of medicine won’t replace tissue — it’ll grow it back. NEW YORK, May 22, 2026 (GLOBE NEWSWIRE) -- Energy Metal News News Commentary — Somew…
Key Points Interested in AxoGen, Inc.? Here are five stocks we like better. AxoGen says its core strategy remains focused on developing the peripheral nerve repair market, and CEO Michael Dale reiterated confidence in the company’s Avance…
ALACHUA, Fla. and TAMPA, Fla., April 30, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that…
Health care stocks edged up late Tuesday afternoon, with the NYSE Health Care Index fractionally hig PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
Image source: The Motley Fool. Date Wednesday, Oct. 29, 2025 at 8 a.m. ET Call participants Chief Executive Officer and Director — Michael Dale Chief Financial Officer — Lindsey Hartley Chief Commercial Officer — Rick Ditto Executive Vice…
Image source: The Motley Fool. DATE Thursday, May 8, 2025 at 8 a.m. ET CALL PARTICIPANTS Chief Executive Officer and Director — Michael Dale Chief Financial Officer — Nir Naor Chief Marketing Officer — Jens Kemp Vice President, Market Acce…
AxoGen logo Key Points Revenue and outlook: Q1 revenue was $61.5 million, up 26.6% year-over-year, with adjusted EBITDA of $5.7 million and management raising full-year 2026 revenue guidance to at least $270 million (≥20% growth). BLA and…
* AxoGen press release [https://seekingalpha.com/pr/20489863-axogen-inc-reports-first-quarter-2026-financial-results] (AXGN [https://seekingalpha.com/symbol/AXGN]): Q1 Non-GAAP EPS of $0.07 in-line. * Revenue of $61.46M (+26.6% Y/Y) beats…
Major earnings expected before the bell on Tuesday include: * The Coca-Cola Company (KO [https://seekingalpha.com/symbol/KO]) * Enterprise Products Partners L.P. (EPD [https://seekingalpha.com/symbol/EPD]) * General Motors Company (GM [htt…
Key Points Acquired 687,600 shares of Axogen; estimated trade size of $22.36 million based on quarterly average pricing Quarter-end stake value rose by $22.78 million, reflecting both the new position and price changes Transaction represen…
What happened According to a recent SEC filing, Capricorn Fund Managers Ltd initiated a new stake in Axogen(NASDAQ:AXGN) during the first quarter of 2026. The fund acquired 687,600 shares, with an estimated transaction value of $22.36 mill…
What happened According to an SEC filing dated April 24, 2026, Capricorn Fund Managers reduced its stake in Waystar(NASDAQ:WAY) by 692,554 shares during the first quarter of 2026. The estimated transaction value was $18.38 million, calcula…
Image source: The Motley Fool. Date Aug. 5, 2025 at 8 a.m. ET Call participants Chief Executive Officer and Director — Michael D. Dale Chief Financial Officer — Lindsey Hartley Chief Commercial Officer — Rick Ditto Vice President, Clinical…
AxoGen (AXGN) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known consensus outlook gives a good sense of the company's earnings pictur…
AxoGen AXGN shares soared 7.5% in the last trading session to close at $37.37. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 12.4% gain over the past four wee…
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The strategy returned 3.70% (gross) an…
Erick Wayne Devinney, Chief Innovation Officer of Axogen, Inc.(NASDAQ:AXGN), reported the exercise of 17,938 options on March 16, 2026, with 5,221 shares of Common Stock sold in the open market for total proceeds of approximately $171,000,…
Key Points DAFNA Capital Management sold 265,456 AXGN shares in the fourth quarter, with an estimated transaction value of $6.53 million based on quarterly average prices. Meanwhile, the quarter-end position value decreased by $2.36 millio…
AxoGen logo AxoGen (NASDAQ:AXGN) executives outlined a year of accelerating commercial momentum, recent balance sheet improvements, and the operational implications of its December Biologics License Application (BLA) approval for AVANCE du…
AxoGen logo Key Points FDA BLA approval for the AVANCE Nerve Graft validates the product, strengthens AxoGen’s position with payers and hesitant physicians, and lets the company consolidate to a single biologics quality system while pursui…
AxoGen, Inc. Q4 2025 Earnings Call Summary - Moby Strategic Execution and Market Development Achieved a critical regulatory milestone with FDA approval of the Biologics License Application (BLA) for Avance, establishing it as the first and…
Image source: The Motley Fool. Date Feb. 24, 2026 at 8 a.m. ET Call participants Chief Executive Officer and Director — Michael Dale Chief Financial Officer — Lindsey Hartley Vice President, Commercial Operations — Rick Ditto Vice Presiden…
AxoGen logo AxoGen (NASDAQ:AXGN) reported fourth-quarter and full-year 2025 results that management said marked a “financial inflection point,” citing accelerating adoption of the company’s nerve repair algorithm, improved operating levera…
AxoGen (AXGN) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.08 per share a year ago. These figures are adjusted for non-recurring items. This q…
Key Points HighMark Wealth Management LLC added 158,855 shares of Axogen. The quarter-end value of the stake rose by $7.9 million, reflecting both trading activity and share price movement. The fund held 343,940 shares valued at $11.2 mill…
In its fourth-quarter 13F filing, HighMark Wealth Management LLC disclosed a purchase of 158,855 shares in Axogen(NASDAQ:AXGN) . This purchase makes the stock one of the firm’s largest holdings. What happened According to its Feb. 4, 2026,…
* AxoGen press release [https://seekingalpha.com/pr/20410315-axogen-inc-reports-fourth-quarter-and-full-year-2025-financial-results] (AXGN [https://seekingalpha.com/symbol/AXGN]): Q4 Non-GAAP EPS of $0.07 misses by $0.03. * Revenue of $59.…